Kojin Therapeutics logo

Kojin Therapeutics

Cambridge, MA

Founded by Stuart Schreiber, Benjamin Cravatt, Stephanie Dougan, and Vasanthi Viswanathan, Kojin is accelerating a drug discovery platform that connects complex cell states to known biochemical processes such as ferroptosis, or iron-dependent cell death, and enables the development of selective therapies for a broad range of hard-to-treat diseases. The company’s investors include Polaris Partners, Newpath Partners, Cathay Health, Leaps by Bayer, AbbVie Inc., Eventide Asset Management, Alexandria, and the Dana-Farber Cancer Institute venture firm, Binney Street Capital.

kojintx.com

Company Details

Founded

2020

Employees

Between 20 - 50 employees

Raised

$60,000,000

Headquarters Location

Cambridge, MA

Public

No

Acquired

No

CEO

Luba GreenwoodLuba Greenwood

Founders

Vasanthi Viswanathan
Vasanthi Viswanathan
Stuart Schreiber
Stuart Schreiber
Benjamin Cravatt
Benjamin Cravatt
Stephanie Dougan
Stephanie Dougan

Company Collections

These are collections Kojin Therapeutics is a part of. Click on the collection name to view similar companies.

Kojin Therapeutics' Industries

Kojin Therapeutics' Tech Stack